ClinVar Miner

Variants from Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine

Location: United States  Primary collection method: clinical testing
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
398 215 112 1 0 714

Gene and significance breakdown #

Total genes and gene combinations: 119
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign total
LDLR 44 41 2 0 79
BRCA2 61 4 1 0 66
BRCA1 32 5 0 0 35
RYR1 6 13 13 0 32
AHDC1 27 0 0 0 27
PMS2 12 6 1 0 19
KCNQ1 9 7 2 0 18
TP53 14 4 0 0 18
CHEK2 10 6 0 0 16
PALB2 10 5 1 0 16
MYBPC3 12 3 0 0 15
DSP 4 3 7 0 14
MSH6 11 3 0 0 14
MYH7 4 10 0 0 14
PKP2 10 2 2 0 14
ATM 9 2 1 0 12
MLH1 7 4 1 0 12
FBN1 2 4 5 0 11
SCN5A 3 6 2 0 11
ATM, C11orf65 6 4 0 0 10
BRCA1, LOC126862571 10 0 0 0 10
POLR2A 1 8 0 1 10
APOB 1 2 6 0 9
KCNH2 3 4 3 0 9
NF1 8 1 0 0 9
TSC2 2 2 5 0 9
DSG2 2 6 0 0 8
COL3A1 1 3 3 0 7
COL5A1 0 0 7 0 7
MSH2 6 1 0 0 7
PTEN 6 1 0 0 7
SDHC 1 4 1 0 6
DSC2 0 1 4 0 5
RET 3 2 0 0 5
RYR2 0 0 5 0 5
TNNI3 2 4 0 0 5
TNNT2 2 2 1 0 5
APC 4 0 0 0 4
KCNE1 2 1 1 0 4
MUTYH 3 1 0 0 4
PCSK9 0 1 3 0 4
SDHA 2 2 0 0 4
CACNA1A 1 0 2 0 3
CACNA1S 0 1 2 0 3
HNF1A 1 0 2 0 3
LMNA 1 2 0 0 3
LOC107303340, VHL 2 1 0 0 3
LPL 2 1 0 0 3
MC4R 1 2 0 0 3
MYH11 0 0 3 0 3
MYLK 0 1 2 0 3
SDHB 2 1 0 0 3
TGFBR2 1 1 1 0 3
TTN 1 2 0 0 3
UMOD 0 3 0 0 3
ACHE 0 0 2 0 2
CBL 1 1 0 0 2
DICER1 2 0 0 0 2
F11 2 0 0 0 2
GLA, RPL36A-HNRNPH2 2 0 0 0 2
HNF1B 0 1 1 0 2
HRAS, LRRC56 2 0 0 0 2
KCNJ2 0 0 2 0 2
LOC126861898, MYH7 1 1 0 0 2
MEN1 0 1 1 0 2
MYH11, NDE1 0 0 2 0 2
NBAS 1 0 1 0 2
TMEM43 0 0 2 0 2
TSC1 0 0 2 0 2
USH2A 0 2 0 0 2
ABCA1 0 1 0 0 1
ACTA2 0 0 1 0 1
ALK 0 1 0 0 1
ANKRD11 1 0 0 0 1
ATP1A2 0 1 0 0 1
BMPR1A 0 1 0 0 1
CCDST, FLG 1 0 0 0 1
CRHR1, KANSL1, MAPT, PLEKHM1, SPPL2C, STH 1 0 0 0 1
CYP21A2, LOC106780800 1 0 0 0 1
DCTN5, PALB2 1 0 0 0 1
DNMT3A, LOC129933290 0 0 1 0 1
ELN 0 1 0 0 1
F5 1 0 0 0 1
FBN1, LOC113939944 0 0 1 0 1
GABRD 0 0 1 0 1
HFE 1 0 0 0 1
INS 1 0 0 0 1
INSL6, JAK2 1 0 0 0 1
KCNE2, LOC105372791 1 0 0 0 1
KIF1A 1 0 0 0 1
KRIT1 1 0 0 0 1
LMNA, LOC126805877 0 1 0 0 1
LOC107982234, WT1 0 0 1 0 1
LOC126806068, RYR2 0 0 1 0 1
LOC126861897, MHRT, MYH7 0 1 0 0 1
LOC126862482, POLR2A 1 0 0 0 1
LOC130062899, STK11 0 0 1 0 1
MED13L 1 0 0 0 1
MEFV 0 1 0 0 1
MYL3 1 0 0 0 1
NDUFAF6 0 1 0 0 1
NEXN 0 1 0 0 1
OTC 1 0 0 0 1
POLE 0 0 1 0 1
PRKAR1A 0 1 0 0 1
PTCH1 0 1 0 0 1
RPSA 0 1 0 0 1
SDHD 1 0 0 0 1
SERPINA1 1 0 0 0 1
SLCO2A1, TF 0 1 0 0 1
SMAD3 0 1 0 0 1
SMAD4 1 0 0 0 1
STING1 1 0 0 0 1
STK11 0 0 1 0 1
TGFB2 1 0 0 0 1
TOR1A 1 0 0 0 1
TPM1 0 0 1 0 1
TUSC3 1 0 0 0 1
WT1 0 1 0 0 1

Condition and significance breakdown #

Total conditions: 122
Download table as spreadsheet
Condition pathogenic likely pathogenic uncertain significance likely benign total
Familial hypercholesterolemia 29 17 8 0 54
Breast-ovarian cancer, familial, susceptibility to, 2 46 3 1 0 50
Hypercholesterolemia, familial, 1 16 26 0 0 42
Rhabdomyosarcoma 36 6 0 0 42
Breast-ovarian cancer, familial, susceptibility to, 1 35 4 0 0 39
Familial cancer of breast 22 6 0 0 28
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 27 0 0 0 27
Malignant hyperthermia, susceptibility to, 1 4 5 13 0 22
Hereditary breast ovarian cancer syndrome 17 3 0 0 20
Arrhythmogenic right ventricular dysplasia 9 10 2 2 0 14
Ataxia-telangiectasia syndrome; Breast cancer, susceptibility to 10 3 1 0 14
Arrhythmogenic right ventricular dysplasia 8 4 2 7 0 13
Hypertrophic cardiomyopathy 1 5 8 0 0 13
Lynch syndrome 6 7 0 0 13
Lynch syndrome 4 9 3 1 0 13
Marfan syndrome 2 4 6 0 12
Colorectal cancer, hereditary nonpolyposis, type 2 7 3 1 0 11
Hypertrophic cardiomyopathy 4 9 2 0 0 11
Hypertrophic cardiomyopathy 3 7 0 0 10
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities 2 8 0 0 10
Arrhythmogenic right ventricular dysplasia 10 2 7 0 0 9
Congenital multicore myopathy with external ophthalmoplegia 1 8 0 0 9
Lynch syndrome 5 7 2 0 0 9
Long QT syndrome 2 2 3 3 0 8
Tuberous sclerosis 2 1 2 5 0 8
Ehlers-Danlos syndrome, classic type, 1 0 0 7 0 7
Ehlers-Danlos syndrome, type 4 1 3 3 0 7
Long QT syndrome 3 4 0 0 7
Long QT syndrome 1 3 4 0 0 7
Long QT syndrome 1; Jervell and Lange-Nielsen syndrome 1 4 1 2 0 7
Pancreatic cancer, susceptibility to, 3; Breast cancer, susceptibility to 3 3 1 0 7
Brugada syndrome 1; Long QT syndrome 3 0 4 2 0 6
Catecholaminergic polymorphic ventricular tachycardia 1 0 0 6 0 6
Li-Fraumeni syndrome 4 2 0 0 6
Aortic aneurysm, familial thoracic 4 0 0 5 0 5
Arrhythmogenic right ventricular dysplasia 11 0 1 4 0 5
Breast cancer, susceptibility to; Prostate cancer susceptibility 1 4 0 0 5
Long QT syndrome 3 3 2 0 0 5
Pheochromocytoma/paraganglioma syndrome 3 1 3 1 0 5
Familial adenomatous polyposis 2 3 1 0 0 4
Hypercholesterolemia, autosomal dominant, 3 0 1 3 0 4
Hypertrophic cardiomyopathy 7 2 2 0 0 4
Lynch syndrome 1 4 0 0 0 4
Multiple endocrine neoplasia type 2A 3 1 0 0 4
Aortic aneurysm, familial thoracic 7 0 1 2 0 3
Dilated cardiomyopathy 1A 0 3 0 0 3
Dilated cardiomyopathy 1G 1 2 0 0 3
Episodic ataxia type 2 1 0 2 0 3
Familial adenomatous polyposis 1 3 0 0 0 3
Familial juvenile hyperuricemic nephropathy type 1 0 3 0 0 3
Hyperlipidemia, familial combined, LPL related 2 1 0 0 3
Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D 0 2 1 0 3
Intellectual disability 3 0 0 0 3
Loeys-Dietz syndrome 2 1 1 1 0 3
Long QT syndrome 5 2 1 0 0 3
Malignant hyperthermia, susceptibility to 2 1 0 0 3
Maturity-onset diabetes of the young type 3 1 0 2 0 3
Obesity 1 2 0 0 3
PTEN hamartoma tumor syndromes 2 1 0 0 3
Pheochromocytoma/paraganglioma syndrome 4 2 1 0 0 3
Von Hippel-Lindau syndrome 2 1 0 0 3
Andersen Tawil syndrome 0 0 2 0 2
Arrhythmogenic right ventricular dysplasia 5 0 0 2 0 2
Cowden syndrome 1 2 0 0 0 2
Dilated cardiomyopathy 1D 2 0 0 0 2
Fabry disease 2 0 0 0 2
Generalized juvenile polyposis/juvenile polyposis coli 1 1 0 0 2
Hypercholesterolemia, autosomal dominant, type B 1 1 0 0 2
Infantile liver failure syndrome 2 1 0 1 0 2
Li-Fraumeni syndrome 1 1 1 0 0 2
Malignant hyperthermia, susceptibility to, 5 0 0 2 0 2
Multiple endocrine neoplasia, type 1 0 1 1 0 2
Peutz-Jeghers syndrome 0 0 2 0 2
Pheochromocytoma/paraganglioma syndrome 5 0 2 0 0 2
Renal cysts and diabetes syndrome 0 1 1 0 2
See cases 0 0 2 0 2
Tuberous sclerosis 1 0 0 2 0 2
Usher syndrome type 2A 0 2 0 0 2
Wilms tumor 1 0 1 1 0 2
Acquired polycythemia vera 1 0 0 0 1
Alpha-1-antitrypsin deficiency 1 0 0 0 1
Aneurysm-osteoarthritis syndrome 0 1 0 0 1
Aortic aneurysm, familial thoracic 6 0 0 1 0 1
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma 0 1 0 0 1
Brugada syndrome 1 0 0 0 1
Cerebral cavernous malformation 1 1 0 0 0 1
Colorectal cancer susceptibility 12 0 0 1 0 1
Congenital adrenal hyperplasia 1 0 0 0 1
Diabetes mellitus, permanent neonatal 4 1 0 0 0 1
Dilated cardiomyopathy 1CC 0 1 0 0 1
Early-onset generalized limb-onset dystonia 1 0 0 0 1
Factor V deficiency 1 0 0 0 1
Factor XI 1 0 0 0 1
Familial Mediterranean fever 0 1 0 0 1
Familial isolated congenital asplenia 0 1 0 0 1
Familial multiple polyposis syndrome 1 0 0 0 1
Fanconi renotubular syndrome 5 0 1 0 0 1
GABRD-related disorder 0 0 1 0 1
Hemochromatosis type 1 1 0 0 0 1
Hereditary factor XI deficiency disease 1 0 0 0 1
Hypertrophic cardiomyopathy 3 0 0 1 0 1
Hypertrophic cardiomyopathy 8 1 0 0 0 1
Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 0 1 0 0 1
Hypoalphalipoproteinemia, primary, 1 0 1 0 0 1
Ichthyosis vulgaris 1 0 0 0 1
Intellectual disability, autosomal dominant 9 1 0 0 0 1
Jervell and Lange-Nielsen syndrome 2; Long QT syndrome 5 0 0 1 0 1
KBG syndrome 1 0 0 0 1
Loeys-Dietz syndrome 4 1 0 0 0 1
Long QT syndrome 6 1 0 0 0 1
Migraine, familial hemiplegic, 2; Alternating hemiplegia of childhood 0 1 0 0 1
Multiple endocrine neoplasia type 2B; Multiple endocrine neoplasia type 2A 0 1 0 0 1
Multiple endocrine neoplasia, type 2 0 1 0 0 1
Ornithine carbamoyltransferase deficiency 1 0 0 0 1
PTEN hamartoma tumor syndrome 1 0 0 0 1
Pheochromocytoma/paraganglioma syndrome 1 1 0 0 0 1
Primary dilated cardiomyopathy 1 0 0 0 1
STING-associated vasculopathy with onset in infancy 1 0 0 0 1
Supravalvar aortic stenosis 0 1 0 0 1
Tatton-Brown-Rahman overgrowth syndrome 0 0 1 0 1
Tuberous sclerosis syndrome 1 0 0 0 1
not specified 0 0 0 1 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The submitted information has not been verified. If you have questions about the information contained on this website, please see a health care professional.